Merignac, France

Christophe Cullin

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Antony, FR (1997)
  • Merignac, FR (2012)

Company Filing History:


Years Active: 1997-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christophe Cullin: Innovator in Anti-Prion Research

Introduction

Christophe Cullin is a prominent inventor based in Merignac, France, recognized for his significant contributions to the field of biotechnology. With a total of two patents to his name, he has made substantial strides in the research and development of anti-prion agents, which hold great promise for addressing neurodegenerative diseases that involve protein aggregates.

Latest Patents

His latest patent focuses on "Screening molecules with anti-prion activity: kits, methods and screened molecules." This innovative invention involves the development of kits designed for screening molecules with anti-prion activity. The kits comprise a [PSI+] phenotype yeast, an antibiogram, and an agent for purifying prions at sub-efficient doses. Notably, the yeast used includes the adel-14 allele of the ADE1 gene and an inactivated ERG6 gene. The screening methods and the resulting family of molecules with anti-prion activity identified through this inventive screen have essential applications in producing medicines for treating neurodegenerative diseases.

Career Highlights

Cullin has been affiliated with reputable institutions such as the Centre National de la Recherche Scientifique and Université Victor Segalen Bordeaux 2. These associations have provided him with a supportive environment to conduct his groundbreaking research and innovate in the crucial area of prion-related diseases.

Collaborations

Throughout his career, Christophe Cullin has collaborated with esteemed colleagues like Denis Pompon and Gilles Truan. These collaborations have facilitated the exchange of knowledge and expertise, enhancing the scope and impact of his research endeavors.

Conclusion

In conclusion, Christophe Cullin stands out as a dedicated inventor whose work in developing anti-prion agents holds significant potential for advancing medical treatments for neurodegenerative conditions. His innovative approach and collaboration with leading scientists underscore his commitment to tackling complex health challenges through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…